Log in

Relevant bibliographies by topics / Fibrocystic mastopathy

Contents

Journal articles
Book chapters

Academic literature on the topic 'Fibrocystic mastopathy'

Author: Grafiati

Published: 4 June 2025

Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Fibrocystic mastopathy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Fibrocystic mastopathy"

1

Смоланка, І. І., А. О. Ляшенко, А. О. Ляшенко, and А. О. Ляшенко. "Fibrocystic mastopathy." Reproductive Endocrinology, no. 18 (November 17, 2014): 17. http://dx.doi.org/10.18370/2309-4117.2014.18.17-23.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Guseynov, Arif. "FIBROCYSTIC MASTOPATHY." Clinical Medicine and Pharmacology 6, no. 3 (2020): 19–32. http://dx.doi.org/10.12737/2409-3750-2020-6-3-19-32.

Full text

Abstract:

The lecture provides information for specialist doctors: oncologists, surgeons, mammologists, general practitioners on the diagnosis and treatment of fibrocystic mastopathy. The current data on the etiology and pathogenesis, classification and clinic of the disease are presented, well-known and new diagnostic methods, advantages and disadvantages of each method are described in detail. Issues of differential diagnostics are highlighted, optimal tactics, methods of conservative and surgical treatment are proposed

APA, Harvard, Vancouver, ISO, and other styles

3

Guseynov, Arif, and M. D'yakov. "ASSESSMENT OF THE EFFECTIVENESS OF YOUNG MASTON IN THE CONSERVATIVE TREATMENT OF FIBROCYSTIC MASTOPATHY IN WOMEN OF REPRODUCTIVE AGE." Clinical Medicine and Pharmacology 10, no. 1 (2024): 2–5. http://dx.doi.org/10.12737/2409-3750-2024-10-1-2-5.

Full text

Abstract:

The paper presents modern approaches to drug therapy for the most common pathology of the mammary glands – fibrocystic mastopathy. The most effective method of conservative treatment of fibrocystic mastopathy in patients of reproductive age is herbal medicine using drugs with anti-estrogenic effects. The indications were determined and the pharmacological action and effectiveness of the drug Mladomaston were assessed. It has been shown that with a 3-month course of administration, the drug provides sufficient effectiveness, expressed primarily in the reduction of pain in the mammary glands and

APA, Harvard, Vancouver, ISO, and other styles

4

Yeszhan, B. G., and S. O. Ossikbayeva. "Study of danazol active agent effect on Mcf10a breast cells redox phosphorylation." Oncologia i radiologia Kazakhstana 60, no. 2 (2021): 32–35. http://dx.doi.org/10.52532/2663-4864-2021-2-60-32-35.

Full text

Abstract:

Fibrocystic mastopathy is one of the most complex breast pathologies, occurring in about 60% of women. The causes and molecular mechanisms of cyst formation in fibrocystic mastopathy are not fully understood, and effective treatment methods are not widely implemented. However, there is evidence of the fibrocystic mastopathy malignization risk. We studied the molecular effect of the active agent danazol on the respiratory complex in mitochondria, which occur in various concentrations and are considered the cell energy center. A method of permeation with special agents was developed to imp

APA, Harvard, Vancouver, ISO, and other styles

5

Yeszhan, B. G., and S. O. Ossikbayeva. "Study of danazol active agent effect on Mcf10a breast cells redox phosphorylation." Oncologia i radiologia Kazakhstana 60, no. 2 (2021): 32–35. http://dx.doi.org/10.52532/2521-6414-2021-2-60-32-35.

Full text

Abstract:

Relevance: Fibrocystic mastopathy is one of the most complex breast pathologies, occurring in about 60% of women. The causes and molecular mechanisms of cyst formation in fibrocystic mastopathy are not fully understood, and effective treatment methods are not widely implemented. However, there is evidence of the fibrocystic mastopathy malignization risk. We studied the molecular effect of the active agent danazol on the respiratory complex in mitochondria, which occur in various concentrations and are considered the cell energy center. A method o

APA, Harvard, Vancouver, ISO, and other styles

6

Ustimov, D. Yu. "On the question of psychogenic factors in the pathogenesis of dyshormonal focal breast diseases." Neurology Bulletin XXXV, no. 1-2 (2003): 50–51. http://dx.doi.org/10.17816/nb89670.

Full text

Abstract:

The successes of psychosomatic medicine have led to the identification of a connection between psychotraumatic factors and diseases such as stomach ulcers, bronchial asthma, hypertension, etc. Psychotropic drugs and psychotherapy have long been used in the complex therapy of these diseases. However, in the treatment of dyshormonal mastopathy (fibroadenosis, nodular fibrocystic mastopathy, fibrotizing adenosis), hormone therapy and surgery still dominate. Meanwhile, the connection between dyshormonal mastopathy and the mental sphere of patients is obvious, but little studied.

APA, Harvard, Vancouver, ISO, and other styles

7

Khomasuridze, A. G., R. A. Manusharova, and N. G. Marsaghishvili. "Use of long-acting contraceptives in therapy of mastopathy." Problems of Endocrinology 40, no. 5 (1994): 29–30. http://dx.doi.org/10.14341/probl12165.

Full text

Abstract:

Effects of long-acting contraceptives on mammary glands of patients with diffuse fibrocystic mastopathy were under study. A total of 206 women aged 17 to 38 were examined. In 50 of them fibrocystic mastopathy was detected by palpation, noncontrast mammography, and ultrasonic examination. On days 5-7 of the cycle the patients were injected 1 ml of depot prover or noristerate or subcutaneously implanted norplant. Injections of the two former agents were repeated in 3 months if necessary. Control examinations were carried out 3 months to 5 years after the contraceptives were started. The results

APA, Harvard, Vancouver, ISO, and other styles

8

Anisimova, Svetlana A., Janna A. Svirina, and Denis A. Maksaev. "Modeling of fibrocystic mastopathy in experiment on animals." I.P. Pavlov Russian Medical Biological Herald 28, no. 4 (2020): 429–36. http://dx.doi.org/10.23888/pavlovj2020284429-436.

Full text

Abstract:

Nowadays, hormonal imbalance is proven to be a factor that influences initiation of malignant and benign breast tumors. To study the aspects of participation of sex hormones in damage to organs and tissues, it may be necessary to model a common womens pathology fibrocystic disease of mammary glands characterized by the most pronounced effects of this pathogenetic factor, on experimental animals. Aim. To create a model of fibrocystic disease of mammary gland with the subsequent possibility of studying morphological manifestations of the disease in natural and drug-induced pathomorphism.&#

APA, Harvard, Vancouver, ISO, and other styles

9

Marcu, Daniela Andreea, and Emese Orban. "Fibrocystic mastopathy: a diagnosis and therapeutic challenge." Medic.ro 2, no. 140 (2021): 28. http://dx.doi.org/10.26416/med.140.2.2021.4929.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Smolanka, I. I., and A. D. Loboda. "Modern view on treatment of patients with fibrocystic mastopathy." HEALTH OF WOMAN, no. 6(112) (July 29, 2016): 149–52. http://dx.doi.org/10.15574/hw.2016.112.149.

Full text

Abstract:

The aim of the study: to determine the effectiveness of the drug Epigalin® Brest in the treatment of fibrocystic breast disease in women. Materials and methods. The study included 50 women with an established diagnosis of fibrocystic breast disease (diffuse cystic mastopathy). All women complained of pain and swelling of both breast 3-20 days before the start of menstruation. By blind randomization, all women were divided into 2 groups. Patients of the first group used the drug Epigalin® Brest 1 tablet 2 times a day for three months. Patients of the second group used the drug prostrate summer

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Fibrocystic mastopathy"

1

Wirsching, M. "Lebensqualität, soziale Unterstützung und Krankheitsbewältigung als Prädiktoren der Gesundheitsentwicklung bei Brustkrebs, Bronchialkrebs und Mastopathia fibrocystica." In Krebs — Bewältigung und Verlauf. Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-75243-8_5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Babu, R. "Fibroadenoma/Cystosarcoma/Breast Cyst/Fibroadenosis/Fibrocystic Disease/ Mastalgia/Mastopathy/Chronic Mastitis." In Clinical Surgery Pearls. Jaypee Brothers Medical Publishers (P) Ltd., 2010. http://dx.doi.org/10.5005/jp/books/11517_51.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Babu, R. "Fibroadenoma/Cystosarcoma/Breast Cyst/Fibroadenosis/Fibrocystic Disease/Mastalgia/Mastopathy/Chronic Mastitis." In Clinical Surgery Pearls. Jaypee Brothers Medical Publishers (P) Ltd., 2013. http://dx.doi.org/10.5005/jp/books/11886_54.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!